Bryan Garnier initiated coverage of Immunocore with a Buy rating and $72 price target.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMCR:
- Immunocore to present four posters at AACR Annual Meeting 2023
- Immunocore reports Q4 EPS (63c), consensus 0c
- Immunocore Reports 2022 Financial Results and Provides Business Update
- Immunocore to present at upcoming investor conferences
- Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023